At the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, we offer three-year pediatric hematology/oncology fellowships in collaboration with Emory University School of Medicine. Our program is one of the largest pediatric hematology/oncology training programs in the country and the premier program in the Southeast.
In conjunction with the Emory Pediatric Fellowship Program, Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Institute of Technology, we also offer a unique pathway for pediatric hematology/oncology fellows to pursue a PhD during the research portion of their fellowships.
The goal of this unique program is to train academically oriented pediatric hematologists and oncologists to be involved in a lifetime of excellence in patient care and teaching while also becoming research scholars with in-depth scientific training, culminating with a PhD in a biomedical discipline.
Our Pediatric Hematology/Oncology Fellowship Program includes:
Our goal is to train academically oriented hematologists and oncologists who will be involved in a lifetime of excellence in pediatric patient care, teaching and research.
Our dual-campus model allows fellows to interact with physicians and subspecialty colleagues in private and academic settings. Our model contributes to some of the country’s largest pediatric patient volumes, exposing fellows to more educational cases and greater research opportunities.
Pediatric Hematology/Oncology Fellowship Program
At the Aflac Cancer and Blood Disorders Center, we offer a three-year fellowship in collaboration with Emory University School of Medicine. Learn more about our program.
2019 Aflac Cancer and Blood Disorders Center program highlights
2019 was an exceptional year for our center. From expanding the team to launching innovative programs, we helped change the future of pediatric cancer and blood disorders.
The Aflac Cancer and Blood Disorders Center provides advanced diagnostic and clinical care, educational programs, psychosocial support, and innovative treatment and research options for children and young adults.
The Aflac Cancer and Blood Disorders Center is:
- One of the leading childhood cancer centers in the country, according to U.S. News & World Report.
- Among the largest pediatric hematology/oncology programs in the country, employing more than 110 faculty members.
- One of the first established National Institutes of Health (NIH) K12- and K30-sponsored clinical research training facilities.
- Ranked No. 1 in the country for Children’s Oncology Group (COG) therapeutic clinical trial enrollment, with more than 400 clinical studies available to our patients.
- A member of the COG Phase I consortium—one of only 21 centers in the country and one of three in the Southeast.
- Generating direct costs of more than $21.3 million each year in extramural research funding, including more than $12.3 million from NIH.
- The largest comprehensive pediatric sickle cell disease program in the country and among the top five hemostasis and thrombosis programs nationally.
- The largest single-center experience in the country for matched-sibling transplants for sickle cell disease.
As one of the largest childhood cancer and blood disorders centers in the country, you’ll gain exposure to a high volume and variety of cases. We care for more than 475 newly diagnosed cancer patients each year and follow more than 2,000 patients with sickle cell disease, hemophilia and other blood disorders. In addition, we have performed more than 1,000 BMTs since our program’s inception, and we follow more than 1,500 survivors through our Cancer Survivor Program.
Our state-of-the-art campus is set to open in 2025
The North Druid Hills campus is designed to improve outcomes, help deliver advanced care and bring lifesaving medical research directly to patients.
Our fellowship program leaders include:
- Daniel Wechsler, MD, PhD, Co-Director
- Kathryn Sutton, MD, Program Director
- Glen Lew, MD, Associate Program Director